Exploring stat-based testing for variables that identify deliberate data manipulation in clinical trials.
Sas Maheswaran
Advertisement
Vice President, Strategic Consulting, with CluePoints
Articles by Sas Maheswaran
Study uncovers insights on the impact on safety, patient enrollment/retention, and compliance.
The long-held practice is effective in pinpointing the emergence of known and unknown risks to clinical development, study shows.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
3
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
4
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
